<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Immunome Res</journal-id><journal-id journal-id-type="pmc-domain-id">361</journal-id><journal-id journal-id-type="pmc-domain">immunres</journal-id><journal-title-group><journal-title xml:lang="en">Immunome Research</journal-title></journal-title-group><issn pub-type="epub">1745-7580</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC2946783</article-id><article-id pub-id-type="pmcid-ver">PMC2946783.1</article-id><article-id pub-id-type="pmcaid">2946783</article-id><article-id pub-id-type="pmcaiid">2946783</article-id><article-id pub-id-type="pmid">20875156</article-id><article-id pub-id-type="doi">10.1186/1745-7580-6-S1-S5</article-id><article-id pub-id-type="publisher-id">1745-7580-6-S1-S5</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Proceedings</subject></subj-group></article-categories><title-group><article-title>Bioinformatics analysis of <italic>Brucella</italic> vaccines and vaccine targets using VIOLIN</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name name-style="western"><surname>He</surname><given-names initials="Y">Yongqun</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>yongqunh@umich.edu</email></contrib><contrib contrib-type="author" id="A2"><name name-style="western"><surname>Xiang</surname><given-names initials="Z">Zuoshuang</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>zxiang@umich.edu</email></contrib></contrib-group><aff id="I1"><label>1</label>Unit for Laboratory Animal Medicine, Department of Microbiology and Immunology, and Center for Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, MI 48109, USA</aff><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>27</day><month>9</month><year>2010</year></pub-date><volume>6</volume><issue>Suppl 1</issue><issue-id pub-id-type="pmc-issue-id">190214</issue-id><supplement><named-content content-type="supplement-title">Ninth International Conference on Bioinformatics (InCoB2010): Immunome Research</named-content><named-content content-type="supplement-editor">Nikolai Petrovsky, Christian Sch&#246;nbach, Kenta Nakai and Shoba Ranganathan</named-content><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.biomedcentral.com/content/pdf/1745-7580-6-S1-info.pdf">http://www.biomedcentral.com/content/pdf/1745-7580-6-S1-info.pdf</ext-link></supplement><fpage>S5</fpage><lpage>S5</lpage><pub-history><event event-type="pmc-release"><date><day>27</day><month>09</month><year>2010</year></date></event><event event-type="pmc-live"><date><day>29</day><month>09</month><year>2010</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-07-24 23:25:10.193"><day>24</day><month>07</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169;2010 He and Xiang; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2010</copyright-year><copyright-holder>He and Xiang; licensee BioMed Central Ltd.</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="1745-7580-6-S1-S5.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.immunome-research.com/content/6/S1/S5"/><abstract><sec><title>Background</title><p><italic>Brucella</italic> spp. are Gram-negative, facultative intracellular bacteria that cause brucellosis, one of the commonest zoonotic diseases found worldwide in humans and a variety of animal species. While several animal vaccines are available, there is no effective and safe vaccine for prevention of brucellosis in humans. VIOLIN (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.violinet.org">http://www.violinet.org</ext-link>) is a web-based vaccine database and analysis system that curates, stores, and analyzes published data of commercialized vaccines, and vaccines in clinical trials or in research. VIOLIN contains information for 454 vaccines or vaccine candidates for 73 pathogens. VIOLIN also contains many bioinformatics tools for vaccine data analysis, data integration, and vaccine target prediction. To demonstrate the applicability of VIOLIN for vaccine research, VIOLIN was used for bioinformatics analysis of existing <italic>Brucella</italic> vaccines and prediction of new <italic>Brucella</italic> vaccine targets. </p></sec><sec><title>Results</title><p>VIOLIN contains many literature mining programs (<italic>e.g.</italic>, Vaxmesh) that provide in-depth analysis of <italic>Brucella</italic> vaccine literature. As a result of manual literature curation, VIOLIN contains information for 38 <italic>Brucella</italic> vaccines or vaccine candidates, 14 protective <italic>Brucella</italic> antigens, and 68 host response studies to <italic>Brucella</italic> vaccines from 97 peer-reviewed articles. These <italic>Brucella</italic> vaccines are classified in the Vaccine Ontology (VO) system and used for different ontological applications. The web-based VIOLIN vaccine target prediction program Vaxign was used to predict new <italic>Brucella</italic> vaccine targets. Vaxign identified 14 outer membrane proteins that are conserved in six virulent strains from <italic>B. abortus</italic>, <italic>B. melitensis</italic>, and <italic>B. suis</italic> that are pathogenic in humans. Of the 14 membrane proteins, two proteins (Omp2b and Omp31-1) are not present in <italic>B. ovis</italic>, a <italic>Brucella</italic> species that is not pathogenic in humans. <italic>Brucella</italic> vaccine data stored in VIOLIN were compared and analyzed using the VIOLIN query system.</p></sec><sec><title>Conclusions</title><p>Bioinformatics curation and ontological representation of <italic>Brucella</italic> vaccines promotes classification and analysis of existing <italic>Brucella</italic> vaccines and vaccine candidates. Computational prediction of <italic>Brucella</italic> vaccine targets provides more candidates for rational vaccine development. The use of VIOLIN provides a general approach that can be applied for analyses of vaccines against other pathogens and infection diseases.  </p></sec></abstract><conference><conf-date>26&#8211;28 September 2010</conf-date><conf-name>Asia Pacific Bioinformatics Network (APBioNet) Ninth International Conference on Bioinformatics (InCoB2010)</conf-name><conf-loc>Tokyo, Japan</conf-loc></conference><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec><title>Background</title><p><italic>Brucella</italic> is a Gram-negative, facultative intracellular bacterium that causes brucellosis in humans and animals [<xref ref-type="bibr" rid="B1">1</xref>]. <italic>Brucella</italic> are taxonomically placed in the alpha-2 subdivision of the class Proteobacteria. Traditionally there are six species of <italic>Brucella</italic> based on the preferential host specificity: <italic>B. melitensis</italic> (goats), <italic>B. abortus</italic> (cattle), <italic>B. suis</italic> (swine), <italic>B. canis</italic> (dogs), <italic>B. ovis</italic> (sheep) and <italic>B. neotomae</italic> (desert mice). The first four species listed in decreasing order of severity are pathogenic to humans making brucellosis a zoonotic disease. These bacteria are also amenable for use in biological warfare and bio-terrorism. Recently, two new species <italic>B. cetaceae</italic> (cetacean) and <italic>B. pinnipediae</italic> (seal) have been described [<xref ref-type="bibr" rid="B2">2</xref>]. Complete genome sequences of 10 <italic>Brucella</italic> strains are currently available in the NCBI RefSeq database. Four genomes from <italic>B. abortus</italic>, <italic>B. melitensis</italic>, and <italic>B. suis</italic> have been extensively analyzed [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B6">6</xref>].  While animal brucellosis vaccines are commercially available, there is no effective and safe human vaccine against virulent <italic>Brucella</italic> infections. Extensive studies on <italic>Brucella</italic> have recently been concentrated on understanding the mechanisms for protective <italic>Brucella</italic> immunity and the development of effective human brucellosis vaccines. </p><p>VIOLIN (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.violinet.org">http://www.violinet.org</ext-link>) is a web-based vaccine database and analysis system. VIOLIN contains general information on microbial pathogenesis, host ranges, and host protective immunity, as well as vaccine-specific information such as vaccine type, preparation method, genetically engineered genes, and host responses in various animal models. VIOLIN contains information about 454 vaccines and vaccine candidates for 73 pathogens. VIOLIN contains many bioinformatics tools for vaccine literature mining, vaccine data analysis and integration, and vaccine target prediction. For example, VIOLIN includes Vaxmesh and Vaxpresso programs that may be used to mine vaccine literature based on MeSH controlled vocabulary and natural language processing (NLP), respectively. Dr. Yongqun He, the founder of the VIOLIN initiated and leads community-based development of the Vaccine Ontology to support vaccine integration and automated reasoning. A web-based vaccine target prediction program Vaxign available in VIOLIN is used to predict vaccine targets based on genome sequence analysis using a reverse vaccinology strategy. </p><p>As of May 13, 2010, more than 2,000 <italic>Brucella</italic> vaccine-related literature papers were searchable in PubMed, and 10 <italic>Brucella</italic> genomes have been published in the NCBI RefSeq database. To support <italic>Brucella</italic> vaccine research and development, we systematically curated from the literature existing <italic>Brucella</italic> vaccine information, which are stored in VIOLIN for query and further analyses. Different VIOLIN tools are also used to analyze <italic>Brucella</italic> vaccines and predict new vaccine targets. </p></sec><sec><title>Results</title><sec><title><italic>Brucella</italic> vaccine literature mining in VIOLIN </title><p>All <italic>Brucella</italic> vaccine-related articles were downloaded from PubMed and stored in VIOLIN. Information for these articles was processed and used for varying literature mining applications in VIOLIN. For example, Vaxmesh, a MeSH-based vaccine literature visualization and mining tool in VIOLIN, was used (Figure <xref ref-type="fig" rid="F1">1</xref>). The Medical Subject Headings (MeSH; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nlm.nih.gov/mesh/">http://www.nlm.nih.gov/mesh/</ext-link>) is the controlled vocabulary thesaurus developed by the National Library of Medicine (NLM) to index articles deposited for the MEDLINE/PubMed database. There are over 25,000 MeSH terms organized in a hierarchical fashion based on 15 top-level categories. The MeSH hierarchical structure permits literature searching at various levels of specificity. Vaxmesh provides an interactive web interface for users to locate articles using MeSH terms in a hierarchical MeSH tree structure.  Figure <xref ref-type="fig" rid="F1">1</xref> demonstrates a MeSH hierarchy for the term &#8220;Gene Deletion&#8221;. This major MeSH term is associated with five papers in <italic>Brucella</italic> vaccine area (Figure <xref ref-type="fig" rid="F1">1A</xref>-<xref ref-type="fig" rid="F1">1B</xref>). A click on the MeSH term links the program to another VIOLIN web page that reveals detailed information about each of the five papers. A web link to PubMed is also available (Figure <xref ref-type="fig" rid="F1">1C</xref>). According the MeSH indexing, those articles associated with <italic>Brucella</italic> vaccines also cover different areas such as anatomy (261 articles), physical sciences (194 articles), and geographic locations (47 articles) (Figure <xref ref-type="fig" rid="F1">1</xref>).  </p><fig id="F1" position="float" orientation="portrait"><label>Figure 1</label><caption><p><bold>Vaxmesh analysis of <italic>Brucella</italic> vaccine papers associated with the MeSH term &#8220;Gene Deletion&#8221;.</bold> (A) Visualization of MeSH hierarchy in Vaxmesh after keyword &#8220;<italic>Brucella</italic>&#8221; search; (B) The two clickable numbers next to each MeSH term links to all publications with the term as a MeSH term or a major MeSH term, respectively. A click on &#8220;5&#8221; next to the MeSH term &#8220;Gene Deletion&#8221; links to another page with detailed citation information; (C) The PubMed record is accessible after a click on an article title in (B).  </p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="1745-7580-6-S1-S5-1.jpg"/></fig><p>Vaxperts is a new MeSH-based VIOLIN program that provides a literature-based social network of vaccine experts based on their publication records in PubMed. Vaxperts allows vaccine experts to find their co-authors and co-authors's co-authors of shared publications. This approach facilitates collaborative vaccine research and development. For example, a search for the keyword &#8220;<italic>Brucella</italic>&#8221; in Vaxperts resulted in the listing of 2454 authors that have contributed to at least one <italic>Brucella</italic> vaccine article.   </p><p>VIOLIN also contains three additional literature mining programs. These are: Vaxpresso, a natural language processing (NLP)-based vaccine literature mining program; VIOLIN Litesearch, an advanced keyword- and category-based search for vaccine literature; and Vaxlert, a literature alert program that provides periodical literature updates through Emails based on the specification of a VIOLIN user. </p></sec><sec><title><italic>Brucella</italic> vaccines curated in VIOLIN </title><p>With many literature mining programs available in VIOLIN, it is possible to make manual curation of <italic>Brucella</italic> vaccine information more efficient. <italic>Brucella</italic> vaccine curation was performed using a web-based literature mining and curation system called Limix [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. Limix was developed to efficiently combine semi-automatic literature mining, manual curation, and data submission. . All curated data includes references. The curated data is published in VIOLIN and available for query only after it is critically reviewed and verified by an expert. </p><p>VIOLIN contains 38 curated <italic>Brucella</italic> vaccines or vaccine candidates that have been officially licensed or proven to provide protection in an animal model (Table <xref ref-type="table" rid="T1">1</xref>). Specifically, VIOLIN includes 20 <italic>B. abortus</italic> vaccines, 16 <italic>B. melitensis</italic> vaccines, and two <italic>B. suis</italic> vaccines. Among them, four <italic>Brucella</italic> vaccines are licensed for commercial uses in cattle, sheep, goat, and pigs. All others are research vaccines which have been demonstrated to induce protection <italic>in vivo</italic> against virulent <italic>Brucella</italic> challenges at least in some laboratory models (mostly in the mouse model). In terms of vaccine types, 1, 8, 10, and 19 vaccines are bacterial vector vaccine, DNA vaccines, subunit vaccines, and live attenuated vaccines,  respectively. </p><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><p><italic>Brucella</italic> vaccines curated in VIOLIN and listed in VO.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">#</th><th colspan="1" rowspan="1">Vaccine names</th><th colspan="1" rowspan="1">VO ID</th><th colspan="1" rowspan="1">Type</th><th colspan="1" rowspan="1">Licensed</th></tr></thead><tbody><tr><td colspan="5" rowspan="1"><italic>Brucella abortus</italic> vaccines</td></tr><tr><td colspan="5" rowspan="1"><hr/></td></tr><tr><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1"><italic>B. abortus</italic> DNA vaccine pcDNA-SOD</td><td colspan="1" rowspan="1">VO_0000018</td><td colspan="1" rowspan="1">DNA</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1"><italic>B. abortus</italic> RB51</td><td colspan="1" rowspan="1">VO_0000021</td><td colspan="1" rowspan="1">LA</td><td colspan="1" rowspan="1">Licensed</td></tr><tr><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1"><italic>B. abortus</italic> strain 19</td><td colspan="1" rowspan="1">VO_0000022</td><td colspan="1" rowspan="1">LA</td><td colspan="1" rowspan="1">Licensed</td></tr><tr><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1"><italic>B. abortus</italic> DNA vaccine encoding BCSP31, SOD and L7/L12</td><td colspan="1" rowspan="1">VO_0000321</td><td colspan="1" rowspan="1">DNA</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1"><italic>B. abortus</italic> subunit vaccine using L7/L12</td><td colspan="1" rowspan="1">VO_0000323</td><td colspan="1" rowspan="1">Sub</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1"><italic>Brucella</italic><italic>abortus</italic> bacA mutant</td><td colspan="1" rowspan="1">VO_0000347</td><td colspan="1" rowspan="1">LA</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">B.  recombinant SurA protein vaccine</td><td colspan="1" rowspan="1">VO_0000358</td><td colspan="1" rowspan="1">Sub</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">B.  recombinant DnaK protein vaccine</td><td colspan="1" rowspan="1">VO_0000373</td><td colspan="1" rowspan="1">Sub</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1"><italic>B. abortus</italic> DNA vaccine using L7/L12 and Omp16</td><td colspan="1" rowspan="1">VO_0000374</td><td colspan="1" rowspan="1">DNA</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">B.  <italic>abortus</italic> DNA vaccine encoding L7/L12 and P39</td><td colspan="1" rowspan="1">VO_0000385</td><td colspan="1" rowspan="1">DNA</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">B.  <italic>abortus</italic> with znuA deletion </td><td colspan="1" rowspan="1">VO_0000386</td><td colspan="1" rowspan="1">LA</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1"><italic>B. abortus</italic> porin-S-LPS </td><td colspan="1" rowspan="1">VO_0000403</td><td colspan="1" rowspan="1">Sub</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1"><italic>B. abortus</italic> RB51WboA</td><td colspan="1" rowspan="1">VO_0000404</td><td colspan="1" rowspan="1">LA</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">Recombinant <italic>O. anthropi</italic> 49237SOD</td><td colspan="1" rowspan="1">VO_0000407</td><td colspan="1" rowspan="1">BT</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1"><italic>B. abortus</italic> pcDNA-BLS</td><td colspan="1" rowspan="1">VO_0000421</td><td colspan="1" rowspan="1">DNA</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">Escheriosome delivery of <italic>B. abortus</italic> L7/L12</td><td colspan="1" rowspan="1">VO_0000423</td><td colspan="1" rowspan="1">Sub</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">17</td><td colspan="1" rowspan="1">NPAP <italic>Brucella</italic> vaccine</td><td colspan="1" rowspan="1">VO_0000450</td><td colspan="1" rowspan="1">IA</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">B.  <italic>abortus</italic> strain RB51SOD</td><td colspan="1" rowspan="1">VO_0000720</td><td colspan="1" rowspan="1">LA</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">B.  <italic>abortus</italic> strain 45/20</td><td colspan="1" rowspan="1">VO_0000723</td><td colspan="1" rowspan="1">LA</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">B.  <italic>abortus</italic> S19 with P39 deletion</td><td colspan="1" rowspan="1">VO_0000826</td><td colspan="1" rowspan="1">LA</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="5" rowspan="1"><hr/></td></tr><tr><td colspan="5" rowspan="1"><italic>Brucella melitensis</italic> vaccines</td></tr><tr><td colspan="5" rowspan="1"><hr/></td></tr><tr><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1"><italic>B. melitensis</italic> Rev. 1 with bp26 and omp31 deletions</td><td colspan="1" rowspan="1">VO_0001171</td><td colspan="1" rowspan="1">LA</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">B.  <italic>melitensis</italic> strain VTRM1</td><td colspan="1" rowspan="1">VO_0000300</td><td colspan="1" rowspan="1">LA</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1"><italic>B. melitensis</italic> lipopolysaccharide vaccine</td><td colspan="1" rowspan="1">VO_0000311</td><td colspan="1" rowspan="1">Sub</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1"><italic>B. melitensis</italic> LPS-GBOMP noncovalent complex </td><td colspan="1" rowspan="1">VO_0000312</td><td colspan="1" rowspan="1">Sub</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1"><italic>B. melitensis</italic> DNA vaccine encoding Omp31</td><td colspan="1" rowspan="1">VO_0000325</td><td colspan="1" rowspan="1">DNA</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">26</td><td colspan="1" rowspan="1">B.  <italic>melitensis</italic> bp26 deletion vaccine</td><td colspan="1" rowspan="1">VO_0000338</td><td colspan="1" rowspan="1">LA</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">27</td><td colspan="1" rowspan="1">B.  <italic>melitensis</italic> WR201</td><td colspan="1" rowspan="1">VO_0000345</td><td colspan="1" rowspan="1">LA</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">28</td><td colspan="1" rowspan="1">B. ovis microparticle subunit vaccine</td><td colspan="1" rowspan="1">VO_0000354</td><td colspan="1" rowspan="1">Sub</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">29</td><td colspan="1" rowspan="1">microencapsulated <italic>B. melitensis</italic> mutant vaccine</td><td colspan="1" rowspan="1">VO_0000398</td><td colspan="1" rowspan="1">LA</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1"><italic>B. melitensis</italic> Bp26 and Tf vaccine</td><td colspan="1" rowspan="1">VO_0000411</td><td colspan="1" rowspan="1">Sub</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">31</td><td colspan="1" rowspan="1"><italic>B. melitensis</italic> P39 recombinant protein vaccine</td><td colspan="1" rowspan="1">VO_0000412</td><td colspan="1" rowspan="1">LA</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">32</td><td colspan="1" rowspan="1">recombinant chimera BLSOmp31</td><td colspan="1" rowspan="1">VO_0000413</td><td colspan="1" rowspan="1">Sub</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">33</td><td colspan="1" rowspan="1"><italic>B. melitensis</italic> DNA vaccine encoding Omp31 boosted with Omp31</td><td colspan="1" rowspan="1">VO_0000436</td><td colspan="1" rowspan="1">DNA</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">34</td><td colspan="1" rowspan="1"><italic>B. melitensis</italic> Rev. 1 with P39 deletion</td><td colspan="1" rowspan="1">VO_0000633</td><td colspan="1" rowspan="1">LA</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">35</td><td colspan="1" rowspan="1">B.  <italic>melitensis</italic> strain Rev. 1</td><td colspan="1" rowspan="1">VO_0000710</td><td colspan="1" rowspan="1">LA</td><td colspan="1" rowspan="1">Licensed</td></tr><tr><td colspan="1" rowspan="1">36</td><td colspan="1" rowspan="1"><italic>Brucella</italic> DNA vaccine encoding chimera BLSOmp31</td><td colspan="1" rowspan="1">VO_0001144</td><td colspan="1" rowspan="1">DNA</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="5" rowspan="1"><hr/></td></tr><tr><td colspan="5" rowspan="1"><italic>Brucella suis</italic> vaccines</td></tr><tr><td colspan="5" rowspan="1"><hr/></td></tr><tr><td colspan="1" rowspan="1">37</td><td colspan="1" rowspan="1"><italic>B. suis</italic> strain VTRS1</td><td colspan="1" rowspan="1">VO_0000303</td><td colspan="1" rowspan="1">LA</td><td colspan="1" rowspan="1">Research</td></tr><tr><td colspan="1" rowspan="1">38</td><td colspan="1" rowspan="1">B.  <italic>suis</italic> strain 2</td><td colspan="1" rowspan="1">VO_0000722</td><td colspan="1" rowspan="1">LA</td><td colspan="1" rowspan="1">Licensed</td></tr></tbody></table><table-wrap-foot><p><bold>Note:</bold> The abbreviations LA, Sub, DNA, Con, IV, and BV represent live attenuated vaccine, subunit vaccine, DNA vaccine, conjugation vaccine, inactivated vaccine, and bacterial vector vaccine, respectively. </p></table-wrap-foot></table-wrap></sec><sec><title>Ontology representation of <italic>Brucella</italic> vaccines</title><p>A biomedical ontology represents the consensus-based controlled vocabularies of terms and relations which are logically formulated in such a way as to promote automated reasoning. Ontologies are able to structure complex biomedical domains and relate the myriad of data to shared understanding of biomedicine. Ontologies can be used for different purposes. The Gene Ontology (GO) is a well-known example of an ontology created for the primary purpose of providing controlled and standardized terms for naming different types of biological processes, cellular components, and molecular functions [<xref ref-type="bibr" rid="B9">9</xref>]. This ontology allows the common representation of attributes of gene products regardless of species of origin. Creating such ontology-based annotations is highly valuable both for querying databases and analyzing high throughput data. This has a significant impact since as of August 2010, over 2,500 peer-reviewed publications are identified through a PubMed search of &#8220;Gene Ontology&#8221;, and approximately 35,000 hits are identified through a Google Scholar search using the same keywords.  Ontologies can also be used for representation of encyclopedic knowledge, data exchange, and computational data analysis and reasoning.  </p><p>The Vaccine Ontology (VO; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.violinet.org/vaccineontology">http://www.violinet.org/vaccineontology</ext-link>) is a collaborative, community-based ontology in the vaccine domain. VO can be used for vaccine data standardization, integration, and computer-assisted reasoning. VO utilizes the Basic Formal Ontology (BFO) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ifomis.org/bfo">http://www.ifomis.org/bfo</ext-link>), a domain-independent ontology, as an upper level ontology. The VO was developed using the W3C standard Web Ontology Language (OWL) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.w3.org/TR/owl-guide/">http://www.w3.org/TR/owl-guide/</ext-link>). The latest version of VO is always available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://purl.obolibrary.org/obo/vo.owl">http://purl.obolibrary.org/obo/vo.owl</ext-link>. In addition, VO has been listed in the OBO (Open Biomedical Ontologies) website (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.obofoundry.org/cgi-bin/detail.cgi?id=vaccine">http://www.obofoundry.org/cgi-bin/detail.cgi?id=vaccine</ext-link>), and deposited in the NCBO BioPortal (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://bioportal.bioontology.org/virtual/1172">http://bioportal.bioontology.org/virtual/1172</ext-link>). To provide a means for users to visualize the definitions and usages of VO terms and their relations, a VO Browser (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.violinet.org/vaccineontology/vobrowser/">http://www.violinet.org/vaccineontology/vobrowser/</ext-link>) was developed.       </p><p>As with other vaccines, <italic>Brucella</italic> vaccines in VO are asserted using single inheritance based on <italic>Brucella</italic> species. Figure <xref ref-type="fig" rid="F2">2A</xref> demonstrates the asserted hierarchy of <italic>B. abortus</italic> vaccines in VO. As an OWL document, VO also supports computational inference with an OWL reasoner, such as FACT++ [<xref ref-type="bibr" rid="B10">10</xref>]. For example, RB51 is asserted under <italic>Brucella</italic><italic> abortus</italic> vaccine (Figure <xref ref-type="fig" rid="F2">2A</xref>). Since RB51 has the qualities of &#8216;live&#8217; and &#8216;attenuated&#8217;, it is also inferred as a &#8216;live attenuated <italic>Brucella</italic> vaccine&#8217; using FACT++ (Figure <xref ref-type="fig" rid="F2">2B</xref>). Figure <xref ref-type="fig" rid="F2">2</xref> provides a screenshot of <italic>Brucella</italic> vaccines listed in VO based on computational reasoning. </p><p>VO has been used in many applications associated with <italic>Brucella</italic> vaccines. It can be used to improve PubMed searching efficiency in the vaccine domain. A user case study would be to search &#8220;live attenuated <italic>Brucella</italic> vaccine&#8221; in PubMed. As of April 10, 2009, a direct PubMed search of this string of keywords returned 56 papers (or PubMed hits). VO includes 13 live attenuated <italic>Brucella</italic> vaccines that have the qualities of &#8216;live&#8217; and &#8216;attenuated&#8217;. When these specific <italic>Brucella</italic> vaccine terms were also included in a PubMed search, the number of positive paper hits in PubMed increased by more than 10-fold [<xref ref-type="bibr" rid="B11">11</xref>]. The combination of VO with SciMiner, a literature mining program, significantly improves PubMed searching efficiency in the general vaccine domain [<xref ref-type="bibr" rid="B12">12</xref>]. It was also found that the application of VO dramatically increased the performance of vaccine-induced IFN- interaction networks [<xref ref-type="bibr" rid="B13">13</xref>]. </p><fig id="F2" position="float" orientation="portrait"><label>Figure 2</label><caption><p><bold>VO hierarchy of <italic>Brucella</italic> vaccines.</bold> (A) Asserted hierarchy; (B) Inferred hierarchy. </p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="1745-7580-6-S1-S5-2.jpg"/></fig><p>Besides vaccine hierarchy, VO can also be used to represent (or model) vaccine investigation. As demonstrated in our two recent reports, vaccine protection investigation can be represented in VO by three continuous steps: vaccination, pathogen challenge, and vaccine efficacy measurement [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. A measurement of vaccine efficacy can be assessed by host survival for the pathogens (<italic>e.g.</italic>, Influenza virus) which kill the infected host (<italic>e.g.</italic>, mouse) [<xref ref-type="bibr" rid="B14">14</xref>] or by pathogen colony forming units (CFU), a measurement for those pathogens (<italic>e.g.</italic>, <italic>Brucella</italic>) which cannot kill infected host but exhibit diminished replication in a vaccinated host than that in unvaccinated host [<xref ref-type="bibr" rid="B15">15</xref>]. It is hypothesized that some parameters will play more important roles than others in determining the protection efficacy of <italic>Brucella</italic> vaccines. To test this hypothesis, the data for 151 groups of <italic>Brucella</italic> vaccine protection investigations were collected in VIOLIN from peer-reviewed literature publications and analyzed using ANOVA. Out of 16 parameters, 10 were found statistically significant (P-value &lt;0.05) in contributing to protection based on a statistical ANOVA analysis. Examples of these parameters included vaccine strain, vaccine viability, vaccination route, vaccination dose. However, other six parameters, including IL-12 vaccine adjuvant, mouse sex, vaccination route, animal age, vaccination-challenge interval, and challenge dose, were not found statistically significant (P-value &gt; 0.05). A careful study of this use case led to building and validating an ontology-based semantic framework to formally represent ANOVA [<xref ref-type="bibr" rid="B15">15</xref>]. Such an ontology-based representation of biomedical data for statistical analysis allows data consistency checking and data sharing in the Semantic Web [<xref ref-type="bibr" rid="B16">16</xref>].   </p></sec><sec><title>Literature curation of <italic>Brucella</italic> protective antigens</title><p>The VIOLIN Protegen program stores protective antigens that have been verified experimentally to induce protective immunity. Protegen contains 14 protective <italic>Brucella</italic> antigens (Table <xref ref-type="table" rid="T2">2</xref>). Among the 14 <italic>Brucella</italic> proteins, four proteins are outer membrane proteins. The other nine proteins are located in cytoplasm (5 proteins), periplasm (4 proteins), and cytoplasmic membrane (1 protein). </p><table-wrap id="T2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Vaxign-predicted vaccine targets from <italic>B. abortus</italic> strain 2308. </p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">#</th><th colspan="1" rowspan="1">Locus Tag</th><th colspan="1" rowspan="1">RefSeq #</th><th colspan="1" rowspan="1">Symbol</th><th colspan="1" rowspan="1">TMH</th><th colspan="1" rowspan="1">Adhesin Prob.</th><th colspan="1" rowspan="1">Con-ed</th><th colspan="1" rowspan="1">Host Simil.</th><th colspan="1" rowspan="1">Protein Notes</th></tr></thead><tbody><tr><td align="center" colspan="9" rowspan="1"><bold>Cell Motility</bold></td></tr><tr><td colspan="9" rowspan="1"><hr/></td></tr><tr><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">BAB2_1097</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_419224.1">YP_419224.1</ext-link></td><td colspan="1" rowspan="1">FlgK </td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0.535</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">flagellar hook-associated protein FlgK </td></tr><tr><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">BAB2_1098</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_419225.1">YP_419225.1</ext-link></td><td colspan="1" rowspan="1">FlgE </td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0.749</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">flagellar hook protein FlgE </td></tr><tr><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">BAB1_0260</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_413736.2">YP_413736.2</ext-link></td><td colspan="1" rowspan="1">FlgJ</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0.656</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Flagellar protein FlgJ:Mannosyl-glycoprotein endo-beta-N-acetylglucosamidase</td></tr><tr><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">BAB1_1726</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_415076.1">YP_415076.1</ext-link></td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0.229</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">hypothetical protein</td></tr><tr><td colspan="9" rowspan="1"><hr/></td></tr><tr><td align="center" colspan="9" rowspan="1"><bold>TonB-dependent Receptor Protein: Inorganic Ion Transport and Metabolism</bold></td></tr><tr><td colspan="9" rowspan="1"><hr/></td></tr><tr><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">BAB2_0233</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_418452.1">YP_418452.1</ext-link></td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0.405</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">TonB-dependent receptor protein</td></tr><tr><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">BAB2_1150</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_419272.1">YP_419272.1</ext-link></td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0.691</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">TonB-dependent receptor protein:Pollen allergen Poa pIX/Phl pVI, C-terminal </td></tr><tr><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">BAB1_1367</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_414742.1">YP_414742.1</ext-link></td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0.655</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">TonB-dependent receptor protein </td></tr><tr><td colspan="9" rowspan="1"><hr/></td></tr><tr><td align="center" colspan="9" rowspan="1"><bold>ATP/GTP-binding Site Motif A (P-loop): Porin, Alpha proteobacteria type</bold></td></tr><tr><td colspan="9" rowspan="1"><hr/></td></tr><tr><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">BAB1_0659</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_414101.1">YP_414101.1</ext-link></td><td colspan="1" rowspan="1">Omp2a </td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0.611</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Porin, alpha proteobacteria type </td></tr><tr><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">BAB1_0660</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_414102.1">YP_414102.1</ext-link></td><td colspan="1" rowspan="1">Omp2b</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0.585</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Porin, alpha proteobacteria type</td></tr><tr><td colspan="9" rowspan="1"><hr/></td></tr><tr><td align="center" colspan="9" rowspan="1"><bold>Cell wall/membrane/envelope Biogenesis</bold></td></tr><tr><td colspan="9" rowspan="1"><hr/></td></tr><tr><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">BAB1_0045</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_413545.1">YP_413545.1</ext-link></td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0.388</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Bacterial surface antigen (D15)</td></tr><tr><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">BAB1_0115</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_413611.1">YP_413611.1</ext-link></td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0.793</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">outer membrane protein, putative</td></tr><tr><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">BAB1_0116</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_413612.1">YP_413612.1</ext-link></td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0.58</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">outer membrane protein, putative</td></tr><tr><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">BAB1_0707</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_414149.1">YP_414149.1</ext-link></td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0.635</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Organic solvent tolerance protein</td></tr><tr><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">BAB1_0722</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_414164.1">YP_414164.1</ext-link></td><td colspan="1" rowspan="1">Omp25</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0.554</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">OmpA-like transmembrane domain</td></tr><tr><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">BAB1_1176</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_414567.1">YP_414567.1</ext-link></td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0.408</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Bacterial surface antigen (D15)</td></tr><tr><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">BAB1_1226</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_414612.1">YP_414612.1</ext-link></td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">0.571</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">MotY protein: OmpA/MotB domain</td></tr><tr><td colspan="1" rowspan="1">17</td><td colspan="1" rowspan="1">BAB1_1302</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_414685.1">YP_414685.1</ext-link></td><td colspan="1" rowspan="1">RopB</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0.815</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">hypothetical protein</td></tr><tr><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">BAB1_1579</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_414943.1">YP_414943.1</ext-link></td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0.669</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">OmpW family</td></tr><tr><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">BAB1_1639</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_414995.1">YP_414995.1</ext-link></td><td colspan="1" rowspan="1">Omp31-1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0.736</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">OmpA-like transmembrane domain</td></tr><tr><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">BAB1_1707</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_415057.1">YP_415057.1</ext-link></td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0.371</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">MotY protein: OmpA/MotB domain</td></tr><tr><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">BAB2_0314</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_418525.1">YP_418525.1</ext-link></td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0.649</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">heat resistant agglutinin 1 precursor</td></tr><tr><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">BAB1_0963</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_414386.1">YP_414386.1</ext-link></td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0.415</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Outer membrane efflux protein</td></tr><tr><td colspan="9" rowspan="1"><hr/></td></tr><tr><td align="center" colspan="9" rowspan="1"><bold>Replication, Recombination and Repair</bold></td></tr><tr><td colspan="9" rowspan="1"><hr/></td></tr><tr><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">BAB2_0636</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_418811.1">YP_418811.1</ext-link></td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0.299</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">DNA topoisomerase I</td></tr><tr><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">BAB1_0121</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_413617.1">YP_413617.1</ext-link></td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0.162</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1">DEAD/DEAH box helicase</td></tr><tr><td colspan="9" rowspan="1"><hr/></td></tr><tr><td align="center" colspan="9" rowspan="1"><bold>Lipid Transport and Metabolism</bold></td></tr><tr><td colspan="9" rowspan="1"><hr/></td></tr><tr><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">BAB1_0967</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_414390.1">YP_414390.1</ext-link></td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0.764</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Membrane protein involved in aromatic hydrocarbon degradation</td></tr><tr><td colspan="9" rowspan="1"><hr/></td></tr><tr><td align="center" colspan="9" rowspan="1"><bold>Posttranslational Modification, Protein Turnover, Chaperones</bold></td></tr><tr><td colspan="9" rowspan="1"><hr/></td></tr><tr><td colspan="1" rowspan="1">26</td><td colspan="1" rowspan="1">BAB1_1944</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_415281.1">YP_415281.1</ext-link></td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0.518</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">PpiC-type peptidyl-prolyl cis-trans isomerase</td></tr><tr><td colspan="9" rowspan="1"><hr/></td></tr><tr><td align="center" colspan="9" rowspan="1"><bold>Unknown Function</bold></td></tr><tr><td colspan="9" rowspan="1"><hr/></td></tr><tr><td colspan="1" rowspan="1">27</td><td colspan="1" rowspan="1">BAB1_1705</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_415055.1">YP_415055.1</ext-link></td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0.594</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">TPR repeat:Molluscan rhodopsin C-terminal tail </td></tr><tr><td colspan="1" rowspan="1">28</td><td colspan="1" rowspan="1">BAB1_1854</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_415198.1">YP_415198.1</ext-link></td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0.759</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">hypothetical protein </td></tr><tr><td colspan="1" rowspan="1">29</td><td colspan="1" rowspan="1">BAB2_0071</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_418316.1">YP_418316.1</ext-link></td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0.492</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">hypothetical protein</td></tr><tr><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">BAB1_0069</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_413569.1">YP_413569.1</ext-link></td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0.886</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">hypothetical protein BAB1_0069 </td></tr><tr><td colspan="1" rowspan="1">31</td><td colspan="1" rowspan="1">BAB1_0897</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_414322.1">YP_414322.1</ext-link></td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">0.279</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Antifreeze protein, type I</td></tr><tr><td colspan="1" rowspan="1">32</td><td colspan="1" rowspan="1">BAB1_0942</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_414367.1">YP_414367.1</ext-link></td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0.346</td><td colspan="1" rowspan="1">X</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">RNA-binding region RNP-1 (RNA recognition motif)</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: TMH, transmembrane helixes; Adhesin Prob., Adhesin probability; Con-ed represents the conserved proteins among five other genomes from virulent <italic>B. abortus</italic> strain 9-941, <italic>B. melitensis</italic> strains 16M and ATCC 23457, and <italic>B. suis</italic> strains 1330 and ATCC 23445; Host Simil., similarity to human and mouse genomes.</p></table-wrap-foot></table-wrap><p>For vaccine development against <italic>Brucella</italic> infections where T cell response is critical, subcellular localization is not usually an issue since a T cell response could be directed to any protein target. Our curated results confirm that protective <italic>Brucella</italic> antigens may occur in different subcellular locations.</p></sec><sec><title>Prediction of potential <italic>Brucella</italic> vaccine targets</title><p>Reverse vaccinology is an emerging vaccine development approach that starts with the prediction of vaccine targets using bioinformatics screening of an entire genome of a pathogenic organism [<xref ref-type="bibr" rid="B17">17</xref>]. As part of VIOLIN, Vaxign is the first web-based vaccine design program that predicts vaccine targets based on reverse vaccinology [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. The Vaxign computational pipeline includes the following features: subcellular localization, topology (transmembrane helices and beta barrel structure), adhesin probability, similarity to other pathogen sequences, similarity to host genome sequences (<italic>e.g.</italic>, human or mouse), and MHC class I and II epitope predictions.  To predict <italic>Brucella</italic> vaccine targets, all 10 sequenced <italic>Brucella</italic> genomes available in NCBI RefSeq were used for a Vaxign analysis.      </p><p>As with other intracellular pathogens, protection against <italic>Brucella</italic> infections requires cell-mediated immunity (CMI). Secreted pathogen proteins are likely to stimulate cytotoxic T lymphocyte (CTL) responses [<xref ref-type="bibr" rid="B20">20</xref>]. However, no <italic>Brucella</italic> protein has been found to be secreted in any <italic>in vitro</italic> culture in a standard culture medium. An O-sialoglycoprotein endopeptidase (Gcp; RefSeq: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_415230.1">YP_415230.1</ext-link>) in <italic>B. abortus</italic> strain 2308 was identified by Vaxign to be a potential secreted protein. This protein is also conserved in the other virulent <italic>B. abortus</italic>, <italic>B. melitensis</italic>, and <italic>B. suis</italic> strains.</p><p>Vaxign was used to predict <italic>Brucella</italic> outer membrane proteins (OMP) as potential vaccine targets using <italic>B. abortus</italic> strain 2308 genome [<xref ref-type="bibr" rid="B6">6</xref>] as the seed genome (Figure <xref ref-type="fig" rid="F3">3</xref>). Among 3034 proteins in this genome, 32 were identified as OMPs. These OMPs from <italic>B. abortus</italic> strain 2308 are listed in Table <xref ref-type="table" rid="T2">2</xref>. Some specific groups such as cell wall/membrane/envelope biogenesis and cell motility were enriched based on the COG analysis [<xref ref-type="bibr" rid="B21">21</xref>]. Two proteins among the 32 OMPs contain more than one transmembrane spanning region each. These two proteins are excluded for further consideration since the presence of multiple transmembrane spanning regions may make the purification of such recombinant proteins difficult [<xref ref-type="bibr" rid="B22">22</xref>]. Adhesins present in  microbial pathogens are essential for bacterial invasion and survival and represent possible targets for vaccine development. If only adhesins are considered, 10 out of the remaining 30 proteins have a probability &lt; 0.51 for being an adhesin and hence were discarded. Fifteen out the remaining 20 proteins are conserved in the genomes from virulent <italic>B. abortus</italic> strain 9-941, <italic>B. melitensis</italic> strain 16M and ATCC 23457, and <italic>B. suis</italic> strains 1330 and ATCC 23445. Each of these strains is pathogenic to humans. One protein (BAB1_1944) has homology with human and mouse proteomes. Among these 14 predicted <italic>Brucella</italic> vaccine targets, Omp25 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_414164.1">YP_414164.1</ext-link>) and Omp31-1 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_414995.1">YP_414995.1</ext-link>) have been verified to be protective <italic>Brucella</italic> antigens [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>]. The list of predicted targets also includes two flagellar hook proteins FlgE (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_419225.1">YP_419225.1</ext-link>) and FlgK (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_419224.1">YP_419224.1</ext-link>), one porin protein Omp2b (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_414102.1">YP_414102.1</ext-link>), and two TonB-dependent receptor proteins BAB1_1367 and BAB2_1150. The roles of these potential proteins as protective <italic>Brucella</italic> antigens have not been studied. The flagellar protein FlgJ appears in <italic>B. abortus</italic> strains 2308 and 9-941, <italic>B. melitensis</italic> strain 16M, and <italic>B. suis</italic> strain ATCC 23445; however, FlgJ is absent from <italic>B. suis</italic> strain 1330 and <italic>B. microti</italic> strain CCM 4915. <italic>Brucella</italic> flagellar genes have recently been found important in <italic>Brucella</italic> survival <italic>in vivo </italic>[<xref ref-type="bibr" rid="B25">25</xref>]. It remains unknown whether these <italic>Brucella</italic> flagellar genes can be used for <italic>Brucella</italic> vaccine development.  </p><fig id="F3" position="float" orientation="portrait"><label>Figure 3</label><caption><p><bold>Prediction of <italic>Brucella</italic> vaccine targets using Vaxign.</bold> *, represents five genomes from virulent <italic>B. abortus</italic> strain 9-941, <italic>B. melitensis</italic> strains 16M and ATCC 23457, and <italic>B. suis</italic> strains 1330 and ATCC 23445. **, represents the genome from <italic>B. ovis</italic> strain ATCC 25840; The indicated two proteins are Omp2b (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_414102.1">YP_414102.1</ext-link>) and Omp31-1 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_414995.1">YP_414995.1</ext-link>). </p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="1745-7580-6-S1-S5-3.jpg"/></fig><p>To develop a human <italic>Brucella</italic> vaccine, those <italic>Brucella</italic> proteins that exist in <italic>Brucella</italic> strains pathogenic to humans but are absent in <italic>Brucella</italic> strains that are non-pathogenic to humans would be ideal for vaccine development. Our studies have identified two proteins, Omp2b (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_414102.1">YP_414102.1</ext-link>) and Omp31-1 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="YP_414995.1">YP_414995.1</ext-link>), which are conserved in the above mentioned virulent <italic>B. abortus</italic>, <italic>B. melitensis</italic>, and <italic>B. suis</italic> strains that are pathogenic to humans, but absent from <italic>B. ovis</italic> that is non-pathogenic to humans. Omp2b and Omp31 are two major outer membrane proteins in <italic>B. abortus </italic>[<xref ref-type="bibr" rid="B26">26</xref>]. It is likely that these two proteins are critical for human-specific <italic>Brucella</italic> infections. If a human <italic>Brucella</italic> vaccine is developed, these two proteins are considered as priority antigens. A further bioinformatics analysis indicates that the porin protein Omp2b does not exist in live attenuated <italic>B. abortus</italic> vaccine strain 19, suggesting that Omp2b likely contributes to the attenuation of this mutant. Omp2b also exists in <italic>B. canis</italic> that is weakly pathogenic to humans.  However, Omp31-1 does not exist in <italic>B. canis</italic>. </p><p>Vaxign identified 46 <italic>Brucella</italic> periplasmic proteins that are conserved in all <italic>B. abortus</italic>, <italic>B. melitensis</italic>, and <italic>B. suis</italic> genomes and lack sequence similarity with proteins in human or mouse genomes. The values of these proteins for vaccine development also deserve further analysis. Using the same criteria (sequence conservation and dissimilarity from human or mouse proteins), Vaxign detected approximately 1,000 cytoplasmic proteins. It is impractical to individually test this high number of proteins for vaccine development. Considering only five cytoplasmic proteins have been experimentally confirmed to be protective antigens out of 1,000 conserved cytoplasmic proteins (Table <xref ref-type="table" rid="T3">3</xref>), it is much less likely that cytoplasmic proteins serve as  protective antigens compared to outer membrane and periplasmic proteins.</p><table-wrap id="T3" position="float" orientation="portrait"><label>Table 3</label><caption><p><italic>Brucella</italic> protective antigens verified experimentally. </p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">#</th><th colspan="1" rowspan="1">Symbol</th><th colspan="1" rowspan="1">Locus tag</th><th colspan="1" rowspan="1">Protein Description</th><th colspan="1" rowspan="1">Location</th><th colspan="1" rowspan="1">References (PMIDs)</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">BLS</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="CAA86936">CAA86936</ext-link></td><td colspan="1" rowspan="1"><italic>Brucella</italic> lumazine synthase</td><td colspan="1" rowspan="1">Cytoplasm</td><td colspan="1" rowspan="1">11953389</td></tr><tr><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">L7/L12</td><td colspan="1" rowspan="1">BRURPL712X</td><td colspan="1" rowspan="1">Ribosomal protein L7/L12</td><td colspan="1" rowspan="1">Cytoplasm</td><td colspan="1" rowspan="1">8873388</td></tr><tr><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">P39</td><td colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="ABM67295">ABM67295</ext-link></td><td colspan="1" rowspan="1">sugar-binding 39-kDa protein</td><td colspan="1" rowspan="1">Periplasm</td><td colspan="1" rowspan="1">11447155 </td></tr><tr><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">Bfr</td><td colspan="1" rowspan="1">BAB2_0675</td><td colspan="1" rowspan="1">Ferritin:Bacterioferritin</td><td colspan="1" rowspan="1">Cytoplasm</td><td colspan="1" rowspan="1">11447155</td></tr><tr><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">Bp26</td><td colspan="1" rowspan="1">BMEI0536</td><td colspan="1" rowspan="1">Periplasmic immunogenic protein</td><td colspan="1" rowspan="1">Periplasm</td><td colspan="1" rowspan="1">17239499</td></tr><tr><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">DnaK</td><td colspan="1" rowspan="1">BruAb1_2100</td><td colspan="1" rowspan="1">Molecular chaperone DnaK</td><td colspan="1" rowspan="1">Cytoplasm</td><td colspan="1" rowspan="1">17686554</td></tr><tr><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">IalB</td><td colspan="1" rowspan="1">BMEI1584</td><td colspan="1" rowspan="1">Invasion protein B</td><td colspan="1" rowspan="1">Cytoplasmic membrane</td><td colspan="1" rowspan="1">17049676</td></tr><tr><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">Omp16</td><td colspan="1" rowspan="1">BAB1_1707</td><td colspan="1" rowspan="1">Outer membrane protein MotY</td><td colspan="1" rowspan="1">Outer membrane</td><td colspan="1" rowspan="1">18981242</td></tr><tr><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">Omp19</td><td colspan="1" rowspan="1">BAB1_1930</td><td colspan="1" rowspan="1">Lipoprotein Omp19</td><td colspan="1" rowspan="1">Outer membrane</td><td colspan="1" rowspan="1">18981242</td></tr><tr><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">Omp25</td><td colspan="1" rowspan="1">BMEI1249</td><td colspan="1" rowspan="1">25 kDa outer-membrane immunogenic protein precursor</td><td colspan="1" rowspan="1">Outer membrane</td><td colspan="1" rowspan="1">18981242</td></tr><tr><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">Omp31</td><td colspan="1" rowspan="1">BAB1_1639</td><td colspan="1" rowspan="1">OmpA-like transmembrane domain</td><td colspan="1" rowspan="1">Outer membrane</td><td colspan="1" rowspan="1">17014873</td></tr><tr><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">SodC </td><td colspan="1" rowspan="1">BAB2_0535</td><td colspan="1" rowspan="1">Cu/Zn superoxide dismutase</td><td colspan="1" rowspan="1">Periplasm</td><td colspan="1" rowspan="1">15039330</td></tr><tr><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">SurA</td><td colspan="1" rowspan="1">BAB1_0706</td><td colspan="1" rowspan="1">Peptidyl-prolyl cis-trans isomerase</td><td colspan="1" rowspan="1">Periplasm</td><td colspan="1" rowspan="1">17686554</td></tr><tr><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">Tig</td><td colspan="1" rowspan="1">BMEI1069</td><td colspan="1" rowspan="1">Trigger factor</td><td colspan="1" rowspan="1">Cytoplasm</td><td colspan="1" rowspan="1">17239499</td></tr></tbody></table></table-wrap><p>Vaxign also contains an epitope prediction component that can predict MHC class I and II binding epitopes [<xref ref-type="bibr" rid="B19">19</xref>]. The addition of epitope prediction allows further analysis for the existence of potential <italic>Brucella</italic> vaccine targets.   </p></sec><sec><title>Other programs in VIOLIN</title><p>VIOLIN provides user-friendly web interface for users to query <italic>Brucella</italic> vaccine data in VIOLIN. For example, Vaxquery is a user-friendly web query tool to query vaccine data (Figure <xref ref-type="fig" rid="F4">4</xref>). </p><fig id="F4" position="float" orientation="portrait"><label>Figure 4</label><caption><p><bold><italic>Brucella</italic> vaccine analyses using VIOLIN Vaxquery.</bold> After typing the &#8220;live attenuated <italic>Brucella </italic><italic>abortus</italic> vaccines&#8221; in the Vaxquery query bar (A), 11 <italic>Brucella</italic> vaccines were displayed (B). Two vaccines (RB51 and RB51SOD) were chosen for advanced comparison (B). After query settings were chosen (C), the results were displayed (E). All curated information has associated references which can be linked to PubMed (E).      </p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="1745-7580-6-S1-S5-4.jpg"/></fig><p>VIOLIN VBLAST is a customized BLAST sequence similarity search program. The BLAST library in VBLAST includes those vaccine-associated genes, including protective antigens, virulent factors whose mutations lead to live attenuated vaccine development, and host protective immune factors. These vaccine-associated genes can also be queried through our Vaxgen web interface. </p><p>Two VIOLIN programs Vaxjo and Vaxvec permit analysis of vaccine adjuvants and vaccine vectors. The adjuvants used for <italic>Brucella</italic> vaccine development include Complete and Incomplete Freund&#8217;s Adjuvants, CpG, Cholera toxin (CT) adjuvant, Maltose binding protein (MBP). </p><p>Additionally, VIOLIN contains the information for host responses to <italic>Brucella</italic> vaccines. Animal response information can be searched through VIOLIN Vaxar (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.violinet.org/vaxar)">http://www.violinet.org/vaxar)</ext-link>.  Currently, annotated information for 68 host response studies of <italic>Brucella</italic> vaccines is available in Vaxar.  VIOLIN contains many pages that are associated with other vaccine related topics, such as vaccine conferences, manufacturers, and useful web links.</p></sec></sec><sec><title>Discussion</title><p>A large number of vaccine-related databases exist on the web. There are many government-supported vaccine databases. For example, the Centers for Disease Control and Prevention (CDC) maintain a Vaccine Information Statements (VISs) system (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.cdc.gov/vaccines/pubs/vis/default.htm">http://www.cdc.gov/vaccines/pubs/vis/default.htm</ext-link>). The Center for Biologics Evaluation and Research (CBER) under the Food and Drug Administration (FDA) regulates vaccine products and posts relevant information in their vaccine site: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.fda.gov/cber/vaccines.htm">http://www.fda.gov/cber/vaccines.htm</ext-link>. There is also a Vaccine Adverse Event Reporting System (VAERS, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://vaers.hhs.gov/">http://vaers.hhs.gov/</ext-link>), co-sponsored by FDA and CDC in USA. Many agent-specific databases are also available, for example, the HIV vaccine resource (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www3.niaid.nih.gov/research/topics/HIV/vaccines/default.htm">http://www3.niaid.nih.gov/research/topics/HIV/vaccines/default.htm</ext-link>) created by the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH). Other vaccine resources include, the Vaccine Page: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.vaccines.org/">http://www.vaccines.org/</ext-link>), the Vaccine Resource Library (PATH, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.path.org/vaccineresources/">http://www.path.org/vaccineresources/</ext-link>), and the Immunization Action Coalition (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.immunize.org/">http://www.immunize.org/</ext-link>).  These databases primarily focus on available information concerning existing licensed vaccines and vaccine regulation. VIOLIN is unique in that it stores and analyzes research data concerning commercial vaccines and vaccines under clinical trial or in early stages of development [<xref ref-type="bibr" rid="B8">8</xref>]. </p><p>The development of the Vaccine Ontology (VO) is a community effort and involves many experts in the vaccine and biomedical ontology communities [<xref ref-type="bibr" rid="B27">27</xref>]. With the large number of vaccine data types and publications available, VO is developed as an efficient strategy for vaccine data standardization, retrieval, and integration. VO makes it possible for computer programs to understand various vaccine types and research data associated with different vaccines. VO will also help to ensure that data is annotated in a way that ensures comparability. Therefore, VO-based software programs can be developed to support high throughput vaccine data processing and analysis. We are currently developing a VO-based literature mining and curation program that would increase the efficacy of vaccine literature mining and manual curation. The VO-based literature mining program will also relieve the burden of continuous database updating. VO will also be used to integrate all vaccine data in VIOLIN, making vaccine information exchange more efficient.</p><p>Compared to the traditional vaccine development approach that starts from a wet laboratory, reverse vaccinology begins with dry laboratory bioinformatics analysis, which makes the vaccine development more specific and efficient. Reverse vaccinology was first used by Rino Rappuoli in the development of a vaccine against serogroup B <italic>Neisseria meningitidis</italic> (MenB), the major cause of sepsis and meningitis in children and young adults [<xref ref-type="bibr" rid="B28">28</xref>]. Since then, this strategy has been applied to many other pathogens such as <italic>Bacillus anthracis </italic>[<xref ref-type="bibr" rid="B29">29</xref>], <italic>Streptococcus pneumoniae </italic>[<xref ref-type="bibr" rid="B30">30</xref>], and <italic>Mycobacterium tuberculosis </italic>[<xref ref-type="bibr" rid="B31">31</xref>]. While the criteria for vaccine prediction are known and many individual programs are available, it is still time consuming and requires expertise in these individual programs to predict vaccine targets using genome sequences. Vaxign is the first web-based automated pipeline that identifies potential vaccine targets based on the reserve vaccinology strategy [<xref ref-type="bibr" rid="B19">19</xref>]. Vaxign has been applied successfully to predict vaccine targets for uropathogenic <italic>E. coli </italic>[<xref ref-type="bibr" rid="B19">19</xref>]. This study demonstrated that Vaxign can predict novel <italic>Brucella</italic> vaccine targets. Experimental verification of many of these targets is currently under way. Vaxign also contains a program to predict immune epitopes that bind to MHC class I and II molecules in different animal species. Studies analyzing and ranking potential immune epitopes from predicted <italic>Brucella</italic> proteins are in progress. Promising epitopes will be tested in a wet laboratory.      </p><p>VIOLIN is also associated with other existing data resources. For example, many VIOLIN programs (<italic>e.g.</italic>, Vaxign and Protegen) obtain <italic>Brucella</italic> genome sequences and share <italic>Brucella</italic> gene annotations with the web-based Pathogen-host Interaction Data Integration and Analysis System (PHIDIAS, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.phidias.us">http://www.phidias.us</ext-link>) [<xref ref-type="bibr" rid="B32">32</xref>]. PHIDIAS focuses on the analysis of pathogen-host interactions. Additionally, PHIDIAS contains the <italic>Brucella</italic> Bioinformatics Portal, a web-based portal with a special emphasis on <italic>Brucella</italic> genome annotation and literature mining [<xref ref-type="bibr" rid="B7">7</xref>]. PHIDIAS and BBP, also developed in our group, integrate more than 20 existing data resources. The close interaction between PHIDIAS/BBP and VIOLIN makes bioinformatics analysis of <italic>Brucella</italic> vaccines and vaccine targets more efficient. </p><p>VIOLIN currently includes vaccine data for 73 pathogens. The VIOLIN methods described for <italic>Brucella</italic> vaccine analysis in this report are generic and also feasible for vaccine studies for other pathogens. It is noted that <italic>Brucella</italic> is one of the most annotated pathogens among these 73 pathogens listed in VIOLIN. The vaccine information for many pathogens is not systematically annotated to the extent of <italic>Brucella</italic> vaccines.  More work and collaborations with the research experts in these pathogens are necessary to curate and analyze vaccines and vaccine candidates for these pathogens.      </p></sec><sec><title>Conclusions</title><p>VIOLIN provides manually curated <italic>Brucella</italic> vaccine data and ontology representation of these vaccines using the Vaccine Ontology (VO). Many tools are developed in VIOLIN to support literature mining and data curation. Examples of data stored in the VIOLIN database include protective <italic>Brucella</italic> antigens and host responses induced by different <italic>Brucella</italic> vaccines. <italic>Brucella</italic> vaccine targets may be predicted using the VIOLIN Vaxign program. Various <italic>Brucella</italic> vaccine data can be queried using user-friendly web query programs in VIOLIN. The VIOLIN approach is generic and can be used for analyses of vaccines against other pathogens and infection diseases.  </p></sec><sec sec-type="methods"><title>Methods</title><p><bold>Literature mining of <italic>Brucella</italic> vaccines using VIOLIN:</bold> The information of all PubMed papers associated with <italic>Brucella</italic> vaccine and vaccination were downloaded from the PubMed web service. The literature contents were processed using VIOLIN literature mining pipelines [<xref ref-type="bibr" rid="B8">8</xref>]. The processed results are available for users to analyzed using individual VIOLIN literature mining programs. </p><p><bold>Bioinformatics curation of <italic>Brucella</italic> vaccines in VIOLIN:</bold><italic> Brucella</italic> vaccine curation was performed on the VIOLIN web page using the Limix literature mining and curation system [<xref ref-type="bibr" rid="B7">7</xref>]. Limix allows data curators to submit data to the website, data reviewers to review and approve the submitted data, and eventual publication of high quality data. Specifically, a VIOLIN curator curates and compiles relevant information on vaccine information from peer-reviewed journals, books, and credible websites. The curated information is initially saved as a draft document and, when completed, is submitted to a MySQL database. The data submitted is initially invisible to the public and subject to critical review by an expert reviewer. Once approved, data becomes public and available for users to query. The database administrator manages users&#8217; accounts and curation tasks. The VIOLIN database is routinely maintained by the database administrator. Published database content is periodically reviewed to ensure that new, pertinent information is captured. When new information is found, a curator and/or a domain expert will update the database content using the standard procedure described above. In addition, the VIOLIN team also periodically emails the authors of new vaccine research publications and encourages them to submit their data through the VIOLIN online submission system. VIOLIN also includes internally developed scripts to automatically update gene annotations based on updated records from existing databases (<italic>e.g.</italic>, NCBI Gene database). </p><p><bold>VO representation of <italic>Brucella</italic> vaccines:</bold> Manually curated <italic>Brucella</italic> vaccines are entered into VO by following the VO development standards [<xref ref-type="bibr" rid="B27">27</xref>]. The VO is edited by Prot&#233;g&#233; (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://protege.stanford.edu/">http://protege.stanford.edu/</ext-link>). The FACT++ OWL reasoner [<xref ref-type="bibr" rid="B10">10</xref>] is used to obtain inferred <italic>Brucella</italic> vaccine hierarchy. </p><p><bold>Vaxign prediction of <italic>Brucella</italic> vaccine targets:</bold> All ten <italic>Brucella</italic> genomes stored in the NCBI RefSeq database were used for prediction of <italic>Brucella</italic> vaccine targets. The genome of <italic>B. abortus</italic> strains 2308 was used as a seed genome. The other genomes include five sequenced virulent strains from three main pathogenic <italic>Brucella</italic> species: <italic>B. abortus</italic> strain 9-941), <italic>B. melitensis</italic> strains 16M and ATCC 23457, and <italic>B. suis</italic> strains 1330 and ATCC 23445. These strain are pathogenic to human. The genome of <italic>Brucella</italic> vaccine strain S19 was also included in this study for comparison purposes. The other three <italic>Brucella</italic> genomes are from <italic>B. ovis</italic> strain ATCC 25840, <italic>B. canis</italic> ATCC 23365, and <italic>B. microti</italic> strain CCM 4915.  More <italic>Brucella</italic> genomes have been sequenced and available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.broadinstitute.org/annotation/genome/brucella_group">http://www.broadinstitute.org/annotation/genome/brucella_group</ext-link>. Since the annotations are not yet finished and their records are not stored in the NCBI RefSeq database, these genomes were not typically used in this study. The Vaxign pipeline was executed by using the <italic>Brucella</italic> genomes as input data. The processed results were stored in the Vaxign database. The Vaxign web query interface was used to query and analyzed the predicted results. </p><p><bold>Query of <italic>Brucella</italic> vaccine information in VIOLIN:</bold> All manually curated or computational processed data can be queried through various VIOLIN web pages. Selected query functions are described in detail in the body of this manuscript. </p></sec><sec><title>List of Abbreviations</title><p>COG: The Clusters of Orthologous Groups; GO: Gene Ontology; Limix: Literature Mining and Curation System; MeSH: Medical Subject Headings; NLM: National Library of Medicine; NCBI: National Center for Biotechnology Information; NCBO: National Center for Biomedical Ontology; OBO: Open Biomedical Ontologies; OWL: Web Ontology Language; SOD: Superoxide Dismutase; VIOLIN: Vaccine Investigation and Online Information Network; VO: Vaccine Ontology; W3C: World Wide Web Consortium.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors&#8217; contributions</title><p>YH: <italic>Brucella</italic> vaccine data analysis, VIOLIN design and project manager, manuscript writing.  </p><p>ZX:  <italic>Brucella</italic> vaccine data analysis, VIOLIN software developer and database administrator, manuscript editing.</p></sec></body><back><sec><title>Acknowledgements</title><p>This manuscript was supported by the NIH-NIAID grant R01AI081062. We appreciate Dr. George W. Jourdian&#8217;s reviews and suggestions.</p><p>This article has been published as part of <italic>Immunome Research</italic> Volume 6 Supplement 1, 2010: Ninth International Conference on Bioinformatics (InCoB2010): Immunome Research.  The full contents of the supplement are available online at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.immunome-research.com/supplements/6/S1">http://www.immunome-research.com/supplements/6/S1</ext-link>.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name name-style="western"><surname>Corbel</surname><given-names>MJ</given-names></name><article-title>Brucellosis: an overview</article-title><source>Emerg Infect Dis</source><year>1997</year><volume>3</volume><issue>2</issue><fpage>213</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.3201/eid0302.970219</pub-id><pub-id pub-id-type="pmid">9204307</pub-id><pub-id pub-id-type="pmcid">PMC2627605</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name name-style="western"><surname>Cloeckaert</surname><given-names>A</given-names></name><name name-style="western"><surname>Verger</surname><given-names>JM</given-names></name><name name-style="western"><surname>Grayon</surname><given-names>M</given-names></name><name name-style="western"><surname>Paquet</surname><given-names>JY</given-names></name><name name-style="western"><surname>Garin-Bastuji</surname><given-names>B</given-names></name><name name-style="western"><surname>Foster</surname><given-names>G</given-names></name><name name-style="western"><surname>Godfroid</surname><given-names>J</given-names></name><article-title>Classification of <italic>Brucella</italic> spp. isolated from marine mammals by DNA polymorphism at the omp2 locus</article-title><source>Microbes Infect</source><year>2001</year><volume>3</volume><issue>9</issue><fpage>729</fpage><lpage>738</lpage><pub-id pub-id-type="doi">10.1016/S1286-4579(01)01427-7</pub-id><pub-id pub-id-type="pmid">11489421</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name name-style="western"><surname>Paulsen</surname><given-names>IT</given-names></name><name name-style="western"><surname>Seshadri</surname><given-names>R</given-names></name><name name-style="western"><surname>Nelson</surname><given-names>KE</given-names></name><name name-style="western"><surname>Eisen</surname><given-names>JA</given-names></name><name name-style="western"><surname>Heidelberg</surname><given-names>JF</given-names></name><name name-style="western"><surname>Read</surname><given-names>TD</given-names></name><name name-style="western"><surname>Dodson</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Umayam</surname><given-names>L</given-names></name><name name-style="western"><surname>Brinkac</surname><given-names>LM</given-names></name><name name-style="western"><surname>Beanan</surname><given-names>MJ</given-names></name><etal/><article-title>The <italic>Brucella</italic><italic> suis</italic> genome reveals fundamental similarities between animal and plant pathogens and symbionts</article-title><source>Proc Natl Acad Sci U S A</source><year>2002</year><volume>99</volume><issue>20</issue><fpage>13148</fpage><lpage>13153</lpage><pub-id pub-id-type="doi">10.1073/pnas.192319099</pub-id><pub-id pub-id-type="pmid">12271122</pub-id><pub-id pub-id-type="pmcid">PMC130601</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name name-style="western"><surname>Halling</surname><given-names>SM</given-names></name><name name-style="western"><surname>Peterson-Burch</surname><given-names>BD</given-names></name><name name-style="western"><surname>Bricker</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Zuerner</surname><given-names>RL</given-names></name><name name-style="western"><surname>Qing</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>LL</given-names></name><name name-style="western"><surname>Kapur</surname><given-names>V</given-names></name><name name-style="western"><surname>Alt</surname><given-names>DP</given-names></name><name name-style="western"><surname>Olsen</surname><given-names>SC</given-names></name><article-title>Completion of the genome sequence of <italic>Brucella abortus</italic> and comparison to the highly similar genomes of <italic>Brucella melitensis</italic> and <italic>Brucella suis</italic></article-title><source>J Bacteriol</source><year>2005</year><volume>187</volume><issue>8</issue><fpage>2715</fpage><lpage>2726</lpage><pub-id pub-id-type="doi">10.1128/JB.187.8.2715-2726.2005</pub-id><pub-id pub-id-type="pmid">15805518</pub-id><pub-id pub-id-type="pmcid">PMC1070361</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name name-style="western"><surname>DelVecchio</surname><given-names>VG</given-names></name><name name-style="western"><surname>Kapatral</surname><given-names>V</given-names></name><name name-style="western"><surname>Redkar</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Patra</surname><given-names>G</given-names></name><name name-style="western"><surname>Mujer</surname><given-names>C</given-names></name><name name-style="western"><surname>Los</surname><given-names>T</given-names></name><name name-style="western"><surname>Ivanova</surname><given-names>N</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>I</given-names></name><name name-style="western"><surname>Bhattacharyya</surname><given-names>A</given-names></name><name name-style="western"><surname>Lykidis</surname><given-names>A</given-names></name><etal/><article-title>The genome sequence of the facultative intracellular pathogen <italic>Brucella melitensis</italic></article-title><source>Proc Natl Acad Sci U S A</source><year>2002</year><volume>99</volume><issue>1</issue><fpage>443</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1073/pnas.221575398</pub-id><pub-id pub-id-type="pmid">11756688</pub-id><pub-id pub-id-type="pmcid">PMC117579</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name name-style="western"><surname>Chain</surname><given-names>PS</given-names></name><name name-style="western"><surname>Comerci</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Tolmasky</surname><given-names>ME</given-names></name><name name-style="western"><surname>Larimer</surname><given-names>FW</given-names></name><name name-style="western"><surname>Malfatti</surname><given-names>SA</given-names></name><name name-style="western"><surname>Vergez</surname><given-names>LM</given-names></name><name name-style="western"><surname>Aguero</surname><given-names>F</given-names></name><name name-style="western"><surname>Land</surname><given-names>ML</given-names></name><name name-style="western"><surname>Ugalde</surname><given-names>RA</given-names></name><name name-style="western"><surname>Garcia</surname><given-names>E</given-names></name><article-title>Whole-genome analyses of speciation events in pathogenic Brucellae</article-title><source>Infect Immun</source><year>2005</year><volume>73</volume><issue>12</issue><fpage>8353</fpage><lpage>8361</lpage><pub-id pub-id-type="doi">10.1128/IAI.73.12.8353-8361.2005</pub-id><pub-id pub-id-type="pmid">16299333</pub-id><pub-id pub-id-type="pmcid">PMC1307078</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name name-style="western"><surname>Xiang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>W</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><article-title>BBP: <italic>Brucella</italic> genome annotation with literature mining and curation</article-title><source>BMC Bioinformatics</source><year>2006</year><volume>7</volume><issue>1</issue><fpage>347</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-7-347</pub-id><pub-id pub-id-type="pmid">16842628</pub-id><pub-id pub-id-type="pmcid">PMC1539029</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name name-style="western"><surname>Xiang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Todd</surname><given-names>T</given-names></name><name name-style="western"><surname>Ku</surname><given-names>KP</given-names></name><name name-style="western"><surname>Kovacic</surname><given-names>BL</given-names></name><name name-style="western"><surname>Larson</surname><given-names>CB</given-names></name><name name-style="western"><surname>Chen</surname><given-names>F</given-names></name><name name-style="western"><surname>Hodges</surname><given-names>AP</given-names></name><name name-style="western"><surname>Tian</surname><given-names>Y</given-names></name><name name-style="western"><surname>Olenzek</surname><given-names>EA</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>B</given-names></name><etal/><article-title>VIOLIN: vaccine investigation and online information network</article-title><source>Nucleic Acids Res</source><year>2008</year><volume>36</volume><issue>Database issue</issue><fpage>D923</fpage><lpage>928</lpage><pub-id pub-id-type="pmid">18025042</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkm1039</pub-id><pub-id pub-id-type="pmcid">PMC2238972</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name name-style="western"><surname>Ashburner</surname><given-names>M</given-names></name><name name-style="western"><surname>Ball</surname><given-names>CA</given-names></name><name name-style="western"><surname>Blake</surname><given-names>JA</given-names></name><name name-style="western"><surname>Botstein</surname><given-names>D</given-names></name><name name-style="western"><surname>Butler</surname><given-names>H</given-names></name><name name-style="western"><surname>Cherry</surname><given-names>JM</given-names></name><name name-style="western"><surname>Davis</surname><given-names>AP</given-names></name><name name-style="western"><surname>Dolinski</surname><given-names>K</given-names></name><name name-style="western"><surname>Dwight</surname><given-names>SS</given-names></name><name name-style="western"><surname>Eppig</surname><given-names>JT</given-names></name><etal/><article-title>Gene ontology: tool for the unification of biology. The Gene Ontology Consortium</article-title><source>Nat Genet</source><year>2000</year><volume>25</volume><issue>1</issue><fpage>25</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1038/75556</pub-id><pub-id pub-id-type="pmid">10802651</pub-id><pub-id pub-id-type="pmcid">PMC3037419</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="other"><name name-style="western"><surname>Tsarkov</surname><given-names>D</given-names></name><name name-style="western"><surname>Horrocks</surname><given-names>I</given-names></name><article-title>FaCT++ Description Logic Reasoner: System Description</article-title><source>Proc of the Int Joint Conf on Automated Reasoning (IJCAR 2006), 4130 of Lecture Notes in Artificial Intelligence</source><year>2006</year><fpage>292</fpage><lpage>297</lpage></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="book"><name name-style="western"><surname>Xiang</surname><given-names>Z</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><article-title>Improvement of PubMed Literature Searching using Biomedical Ontology.</article-title><source>The 1st International Conference on Biomedical Ontology (ICBO 2009) Nature Precedings</source><year>2009</year><publisher-name>Buffalo, NY, USA</publisher-name><comment>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://precedingsnaturecom/documents/3491/version/1">http://precedingsnaturecom/documents/3491/version/1</ext-link> August 24-26, 2009 2009</comment></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="other"><name name-style="western"><surname>Hur</surname><given-names>J</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Feldman</surname><given-names>E</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><article-title>Ontology-based vaccine literature mining and indexing.</article-title><source>Bio-Ontologies 2010: Semantic Applications in Life Sciences, 18th Annual International Conference on Intelligent Systems for Molecular Biology (ISMB): 2010; Boston, MA, USA. August 11-13</source><year>2010</year></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="other"><name name-style="western"><surname>Ozgur</surname><given-names>A</given-names></name><name name-style="western"><surname>Radev</surname><given-names>DR</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>Z</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><article-title>Mining of vaccine-associated IFN-&#947; gene interaction networks using the Vaccine Ontology.</article-title><source>Bio-Ontologies 2010: Semantic Applications in Life Sciences, 18th Annual International Conference on Intelligent Systems for Molecular Biology (ISMB): 2010; Boston, MA, USA</source><year>2010</year><fpage>4</fpage><comment>page full paper (Accepted)</comment></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="other"><name name-style="western"><surname>Brinkman</surname><given-names>RR</given-names></name><name name-style="western"><surname>Courtot</surname><given-names>M</given-names></name><name name-style="western"><surname>Derom</surname><given-names>D</given-names></name><name name-style="western"><surname>Fostel</surname><given-names>J</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lord</surname><given-names>P</given-names></name><name name-style="western"><surname>Malone</surname><given-names>J</given-names></name><name name-style="western"><surname>Parkinson</surname><given-names>H</given-names></name><name name-style="western"><surname>Peters</surname><given-names>B</given-names></name><name name-style="western"><surname>Rocca-Serra</surname><given-names>P</given-names></name><etal/><article-title>Modeling biomedical experimental processes with OBI.</article-title><source>Journal of Biomedical Semantics</source><year>2010</year><comment>Accepted</comment><pub-id pub-id-type="pmid">20626927</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/2041-1480-1-S1-S7</pub-id><pub-id pub-id-type="pmcid">PMC2903726</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="other"><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Todd</surname><given-names>T</given-names></name><name name-style="western"><surname>Courtot</surname><given-names>M</given-names></name><name name-style="western"><surname>Brinkman</surname><given-names>RR</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>J</given-names></name><name name-style="western"><surname>Stoeckert</surname><given-names>CJ</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Malone</surname><given-names>J</given-names></name><name name-style="western"><surname>Rocca-Serra</surname><given-names>P</given-names></name><name name-style="western"><surname>Sansone</surname><given-names>SA</given-names></name><etal/><article-title>Ontology representation and ANOVA analysis of vaccine protection investigation.</article-title><source>Bio-Ontologies 2010: Semantic Applications in Life Sciences, 18th Annual International Conference on Intelligent Systems for Molecular Biology (ISMB): 2010; Boston, MA, USA</source><year>2010</year><fpage>4</fpage><comment>page full paper (Accepted)</comment></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name name-style="western"><surname>Ruttenberg</surname><given-names>A</given-names></name><name name-style="western"><surname>Clark</surname><given-names>T</given-names></name><name name-style="western"><surname>Bug</surname><given-names>W</given-names></name><name name-style="western"><surname>Samwald</surname><given-names>M</given-names></name><name name-style="western"><surname>Bodenreider</surname><given-names>O</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name><name name-style="western"><surname>Doherty</surname><given-names>D</given-names></name><name name-style="western"><surname>Forsberg</surname><given-names>K</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kashyap</surname><given-names>V</given-names></name><article-title>Advancing translational research with the Semantic Web</article-title><source>BMC Bioinformatics</source><year>2007</year><volume>8</volume><issue>Suppl 3</issue><fpage>S2</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-8-S3-S2</pub-id><pub-id pub-id-type="pmid">17493285</pub-id><pub-id pub-id-type="pmcid">PMC1892099</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name name-style="western"><surname>Rappuoli</surname><given-names>R</given-names></name><article-title>Reverse vaccinology</article-title><source>Curr Opin Microbiol</source><year>2000</year><volume>3</volume><issue>5</issue><fpage>445</fpage><lpage>450</lpage><pub-id pub-id-type="doi">10.1016/S1369-5274(00)00119-3</pub-id><pub-id pub-id-type="pmid">11050440</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="other"><name name-style="western"><surname>Xiang</surname><given-names>Z</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><article-title>Vaxign: a web-based vaccine target design program for reverse vaccinology.</article-title><source>Procedia in Vaccinology: 2009; 2nd Global Congress on Vaccines, December 7-9, 2008, Boston, MA, USA</source><year>2009</year><fpage>23</fpage><lpage>29</lpage></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Mobley</surname><given-names>HL</given-names></name><article-title>Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development.</article-title><source>Journal of Biomedicine and Biotechnology</source><year>2010</year><volume>2010</volume><comment>(2010), Article ID 297505, 15 pages</comment><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2010/297505</pub-id><pub-id pub-id-type="pmcid">PMC2910479</pub-id><pub-id pub-id-type="pmid">20671958</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name name-style="western"><surname>Kaufmann</surname><given-names>SH</given-names></name><name name-style="western"><surname>Hess</surname><given-names>J</given-names></name><article-title>Impact of intracellular location of and antigen display by intracellular bacteria: implications for vaccine development</article-title><source>Immunol Lett</source><year>1999</year><volume>65</volume><issue>1-2</issue><fpage>81</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/S0165-2478(98)00128-X</pub-id><pub-id pub-id-type="pmid">10065631</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name name-style="western"><surname>Tatusov</surname><given-names>RL</given-names></name><name name-style="western"><surname>Galperin</surname><given-names>MY</given-names></name><name name-style="western"><surname>Natale</surname><given-names>DA</given-names></name><name name-style="western"><surname>Koonin</surname><given-names>EV</given-names></name><article-title>The COG database: a tool for genome-scale analysis of protein functions and evolution</article-title><source>Nucleic Acids Res</source><year>2000</year><volume>28</volume><issue>1</issue><fpage>33</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1093/nar/28.1.33</pub-id><pub-id pub-id-type="pmid">10592175</pub-id><pub-id pub-id-type="pmcid">PMC102395</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="book"><name name-style="western"><surname>Serruto</surname><given-names>D</given-names></name><name name-style="western"><surname>Rappuoli</surname><given-names>R</given-names></name><name name-style="western"><surname>Pizza</surname><given-names>M</given-names></name><person-group person-group-type="editor">Grandi G</person-group><article-title>Meningococcus B: from Genome to Vaccine.</article-title><source>Genomics, Proteomics and Vaccines</source><year>2004</year><publisher-name>John Wiley &amp; Sons Ltd.</publisher-name><fpage>185</fpage><lpage>201</lpage></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name name-style="western"><surname>Commander</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Spencer</surname><given-names>SA</given-names></name><name name-style="western"><surname>Wren</surname><given-names>BW</given-names></name><name name-style="western"><surname>MacMillan</surname><given-names>AP</given-names></name><article-title>The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding <italic>Brucella melitensis</italic> 16M genes</article-title><source>Vaccine</source><year>2007</year><volume>25</volume><issue>1</issue><fpage>43</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2006.07.046</pub-id><pub-id pub-id-type="pmid">17049676</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name name-style="western"><surname>Cassataro</surname><given-names>J</given-names></name><name name-style="western"><surname>Velikovsky</surname><given-names>CA</given-names></name><name name-style="western"><surname>Bruno</surname><given-names>L</given-names></name><name name-style="western"><surname>Estein</surname><given-names>SM</given-names></name><name name-style="western"><surname>de la Barrera</surname><given-names>S</given-names></name><name name-style="western"><surname>Bowden</surname><given-names>R</given-names></name><name name-style="western"><surname>Fossati</surname><given-names>CA</given-names></name><name name-style="western"><surname>Giambartolomei</surname><given-names>GH</given-names></name><article-title>Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding <italic>Brucella melitensis</italic> outer membrane protein 31 (Omp31) and recombinant Omp31 boosting</article-title><source>Clin Vaccine Immunol</source><year>2007</year><volume>14</volume><issue>7</issue><fpage>869</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.1128/CVI.00472-06</pub-id><pub-id pub-id-type="pmid">17428946</pub-id><pub-id pub-id-type="pmcid">PMC1951060</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name name-style="western"><surname>Fretin</surname><given-names>D</given-names></name><name name-style="western"><surname>Fauconnier</surname><given-names>A</given-names></name><name name-style="western"><surname>Kohler</surname><given-names>S</given-names></name><name name-style="western"><surname>Halling</surname><given-names>S</given-names></name><name name-style="western"><surname>Leonard</surname><given-names>S</given-names></name><name name-style="western"><surname>Nijskens</surname><given-names>C</given-names></name><name name-style="western"><surname>Ferooz</surname><given-names>J</given-names></name><name name-style="western"><surname>Lestrate</surname><given-names>P</given-names></name><name name-style="western"><surname>Delrue</surname><given-names>RM</given-names></name><name name-style="western"><surname>Danese</surname><given-names>I</given-names></name><etal/><article-title>The sheathed flagellum of <italic>Brucella melitensis</italic> is involved in persistence in a murine model of infection</article-title><source>Cell Microbiol</source><year>2005</year><volume>7</volume><issue>5</issue><fpage>687</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1111/j.1462-5822.2005.00502.x</pub-id><pub-id pub-id-type="pmid">15839898</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name name-style="western"><surname>Connolly</surname><given-names>JP</given-names></name><name name-style="western"><surname>Comerci</surname><given-names>D</given-names></name><name name-style="western"><surname>Alefantis</surname><given-names>TG</given-names></name><name name-style="western"><surname>Walz</surname><given-names>A</given-names></name><name name-style="western"><surname>Quan</surname><given-names>M</given-names></name><name name-style="western"><surname>Chafin</surname><given-names>R</given-names></name><name name-style="western"><surname>Grewal</surname><given-names>P</given-names></name><name name-style="western"><surname>Mujer</surname><given-names>CV</given-names></name><name name-style="western"><surname>Ugalde</surname><given-names>RA</given-names></name><name name-style="western"><surname>DelVecchio</surname><given-names>VG</given-names></name><article-title>Proteomic analysis of <italic>Brucella abortus </italic>cell envelope and identification of immunogenic candidate proteins for vaccine development</article-title><source>Proteomics</source><year>2006</year><volume>6</volume><issue>13</issue><fpage>3767</fpage><lpage>3780</lpage><pub-id pub-id-type="doi">10.1002/pmic.200500730</pub-id><pub-id pub-id-type="pmid">16739129</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="book"><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cowell</surname><given-names>L</given-names></name><name name-style="western"><surname>Diehl</surname><given-names>AD</given-names></name><name name-style="western"><surname>Mobley</surname><given-names>HL</given-names></name><name name-style="western"><surname>Peters</surname><given-names>B</given-names></name><name name-style="western"><surname>Ruttenberg</surname><given-names>A</given-names></name><name name-style="western"><surname>Scheuermann</surname><given-names>RH</given-names></name><name name-style="western"><surname>Brinkman</surname><given-names>RR</given-names></name><name name-style="western"><surname>Courtot</surname><given-names>M</given-names></name><name name-style="western"><surname>Mungall</surname><given-names>C</given-names></name><etal/><article-title>VO: Vaccine Ontology.</article-title><source>The 1st International Conference on Biomedical Ontology (ICBO 2009) Nature Precedings</source><year>2009</year><publisher-name>Buffalo, NY, USA</publisher-name><comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://precedings.nature.com/documents/3553/version/1">http://precedings.nature.com/documents/3553/version/1</ext-link></comment></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name name-style="western"><surname>Pizza</surname><given-names>M</given-names></name><name name-style="western"><surname>Scarlato</surname><given-names>V</given-names></name><name name-style="western"><surname>Masignani</surname><given-names>V</given-names></name><name name-style="western"><surname>Giuliani</surname><given-names>MM</given-names></name><name name-style="western"><surname>Arico</surname><given-names>B</given-names></name><name name-style="western"><surname>Comanducci</surname><given-names>M</given-names></name><name name-style="western"><surname>Jennings</surname><given-names>GT</given-names></name><name name-style="western"><surname>Baldi</surname><given-names>L</given-names></name><name name-style="western"><surname>Bartolini</surname><given-names>E</given-names></name><name name-style="western"><surname>Capecchi</surname><given-names>B</given-names></name><etal/><article-title>Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing</article-title><source>Science</source><year>2000</year><volume>287</volume><issue>5459</issue><fpage>1816</fpage><lpage>1820</lpage><pub-id pub-id-type="doi">10.1126/science.287.5459.1816</pub-id><pub-id pub-id-type="pmid">10710308</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name name-style="western"><surname>Ariel</surname><given-names>N</given-names></name><name name-style="western"><surname>Zvi</surname><given-names>A</given-names></name><name name-style="western"><surname>Grosfeld</surname><given-names>H</given-names></name><name name-style="western"><surname>Gat</surname><given-names>O</given-names></name><name name-style="western"><surname>Inbar</surname><given-names>Y</given-names></name><name name-style="western"><surname>Velan</surname><given-names>B</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>S</given-names></name><name name-style="western"><surname>Shafferman</surname><given-names>A</given-names></name><article-title>Search for potential vaccine candidate open reading frames in the <italic>Bacillus anthracis</italic> virulence plasmid pXO1: in silico and in vitro screening</article-title><source>Infect Immun</source><year> 2002</year><volume>70</volume><issue>12</issue><fpage>6817</fpage><lpage>6827</lpage><pub-id pub-id-type="doi">10.1128/IAI.70.12.6817-6827.2002</pub-id><pub-id pub-id-type="pmid">12438358</pub-id><pub-id pub-id-type="pmcid">PMC133087</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name name-style="western"><surname>Wizemann</surname><given-names>TM</given-names></name><name name-style="western"><surname>Heinrichs</surname><given-names>JH</given-names></name><name name-style="western"><surname>Adamou</surname><given-names>JE</given-names></name><name name-style="western"><surname>Erwin</surname><given-names>AL</given-names></name><name name-style="western"><surname>Kunsch</surname><given-names>C</given-names></name><name name-style="western"><surname>Choi</surname><given-names>GH</given-names></name><name name-style="western"><surname>Barash</surname><given-names>SC</given-names></name><name name-style="western"><surname>Rosen</surname><given-names>CA</given-names></name><name name-style="western"><surname>Masure</surname><given-names>HR</given-names></name><name name-style="western"><surname>Tuomanen</surname><given-names>E</given-names></name><etal/><article-title>Use of a whole genome approach to identify vaccine molecules affording protection against <italic>Streptococcus pneumoniae</italic> infection</article-title><source>Infect Immun</source><year>2001</year><volume>69</volume><issue>3</issue><fpage>1593</fpage><lpage>1598</lpage><pub-id pub-id-type="doi">10.1128/IAI.69.3.1593-1598.2001</pub-id><pub-id pub-id-type="pmid">11179332</pub-id><pub-id pub-id-type="pmcid">PMC98061</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name name-style="western"><surname>Betts</surname><given-names>JC</given-names></name><article-title>Transcriptomics and proteomics: tools for the identification of novel drug targets and vaccine candidates for tuberculosis</article-title><source>IUBMB Life</source><year>2002</year><volume>53</volume><issue>45</issue><fpage>239</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1080/15216540212651</pub-id><pub-id pub-id-type="pmid">12121002</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name name-style="western"><surname>Xiang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Tian</surname><given-names>Y</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><article-title>PHIDIAS: a pathogen-host interaction data integration and analysis system</article-title><source>Genome Biol</source><year>2007</year><volume>8</volume><issue>7</issue><fpage>R150</fpage><pub-id pub-id-type="doi">10.1186/gb-2007-8-7-r150</pub-id><pub-id pub-id-type="pmid">17663773</pub-id><pub-id pub-id-type="pmcid">PMC2323235</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>